Home » Topics » BioWorld Science

BioWorld Science
RSS

Hanmi Science divulges new EZH inhibitors

March 11, 2022

New York Blood Center patents new antiviral compounds

March 11, 2022

Discovery of novel antioxidant, antiedematogenic and antinociceptive compound

March 11, 2022

Researchers present a promising approach for efficient solid tumor cell killing

March 11, 2022

Discovery of novel orally active FXR agonist with improved potency

March 11, 2022

Immuneering advances dual-MEK inhibitors

March 10, 2022

Colonic IL-22 protects intestinal mucosal barrier in severe acute pancreatitis

March 10, 2022

Series A financing at Scenic Biotech to support immuno-oncology and rare inherited disease pipeline

March 10, 2022

NexImmune advances early-stage programs

March 10, 2022

Immunoprecise reports in vivo data on PolyTope TATX-03 antibody cocktail therapy

March 10, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...